Health-related quality of life (HRQOL) with pembrolizumab (pembro) plus trastuzumab (tras) and chemotherapy (chemo) in first-line HER2-positive (HER2+) advanced gastric cancer: KEYNOTE-811 trial results

Janjigian Y. Y., Kawazoe A., Xu J., Lonardi S., Metges J., Wyrwicz L. S., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, sa.3_SUPPL, ss.286, 2024 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Özet
  • Basım Tarihi: 2024
  • Doi Numarası: 10.1200/jco.2024.42.3_suppl.286
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database
  • Sayfa Sayıları: ss.286
  • Atatürk Üniversitesi Adresli: Evet